Rare diseases
Investigational molecules
Locations
220 Montgomery Street Suite 484, 94104-3400, United States
The Scleroderma Research Foundation focuses on clinical research in systemic sclerosis, with particular attention to interstitial lung disease associated with scleroderma (SSc-ILD).
Its funded research activity is centered on pulmonary complications of scleroderma, especially conditions affecting breathing and lung function.
Scleroderma Research Foundation runs clinical trials in conditions such as Systemic scleroderma, Interstitial lung disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
